At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
formoterol +2 moredrug
Likely dose
formoterol 24 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Evaluate the Dose-response of Inhaled Formoterol to Inhibit Airway Responsiveness to Methacholine in Patients With Mild Asthma
In Brief
A clinical study evaluating formoterol and Dry Powder Inhaler (Twisthaler) for Asthma. Completed, enrolled 37 participants across 1 site.
Detailed Summary
The purpose of this study is to find out whether a difference between two doses of formoterol can be detected by methacholine challenge.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsTeva Branded Pharmaceutical Products R&D, Inc.
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedMar 2008
Primary CompletionJan 2009
TodayJul 2026
First PostedMar 26, 2008
Enrollment StartMar 1, 2008
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 18.3 years ago
Interventions
formoteroldrug
a single dose of 24 mcg of formoterol delivered by dry powder inhaler (Twisthaler)
formoteroldrug
a single dose of 12 mcg of formoterol delivered by dry powder inhaler (Twisthaler)
Dry Powder Inhaler (Twisthaler)device
subjects inhaled deeply and forcefully and held their breath for 10 seconds for each dose